January 2nd, 2020, Jefferies Financial Group lowered price target for Organigram (TSX, NASDAQ: OGI) from $8.20 to $5.
|1/2/2020||Jefferies Financial Group||Lower Price Target||C$8.20 ➝ C$5.00|
|11/26/2019||Cormark||Lower Price Target||C$10.00 ➝ C$4.50|
|11/26/2019||Haywood Securities||Lower Price Target||C$8.00 ➝ C$7.50|
|11/26/2019||Pi Financial||Set Price Target||Buy||C$7.00|
|11/26/2019||Raymond James||Set Price Target||Outperform||C$9.00|
|11/13/2019||Canaccord Genuity||Lower Price Target||C$8.50 ➝ C$7.00|
|11/12/2019||AltaCorp Capital||Lower Price Target||C$13.15 ➝ C$6.50|
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.
Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
Disclaimer: All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional.